Literature DB >> 23042953

Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter.

Denis O Sviridov1, Alexander M Andrianov, Ivan V Anishchenko, John A Stonik, Marcelo J A Amar, Scott Turner, Alan T Remaley.   

Abstract

The bihelical apolipoprotein mimetic peptide 5A effluxes cholesterol from cells and reduces inflammation and atherosclerosis in animal models. We investigated how hydrophobic residues in the hinge region between the two helices are important in the structure and function of this peptide. By simulated annealing analysis and molecular dynamics modeling, two hydrophobic amino acids, F-18 and W-21, in the hinge region were predicted to be relatively surface-exposed and to interact with the aqueous solvent. Using a series of 5A peptide analogs in which F-18 or W-21 was changed to either F, W, A, or E, only peptides with hydrophobic amino acids in these two positions were able to readily bind and solubilize phospholipid vesicles. Compared with active peptides containing F or W, peptides containing E in either of these two positions were more than 10-fold less effective in effluxing cholesterol by the ABCA1 transporter. Intravenous injection of 5A in C57BL/6 mice increased plasma-free cholesterol (5A: 89.9 ± 13.6 mg/dl; control: 38.7 ± 4.3 mg/dl (mean ± S.D.); P < 0.05) and triglycerides (5A: 887.0 ± 172.0 mg/dl; control: 108.9 ± 9.9 mg/dl; P < 0.05), whereas the EE peptide containing E in both positions had no effect. Finally, 5A increased cholesterol efflux approximately 2.5-fold in vivo from radiolabeled macrophages, whereas the EE peptide was inactive. These results provide a rationale for future design of therapeutic apolipoprotein mimetic peptides and provide new insights into the interaction of hydrophobic residues on apolipoproteins with phospholipids in the lipid microdomain created by the ABCA1 transporter during the cholesterol efflux process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23042953      PMCID: PMC3533411          DOI: 10.1124/jpet.112.198143

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

1.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

2.  Rotational and hinge dynamics of discoidal high density lipoproteins probed by interchain disulfide bond formation.

Authors:  Ling Li; Songlin Li; Martin K Jones; Jere P Segrest
Journal:  Biochim Biophys Acta       Date:  2011-10-19

3.  Interaction of plasma high density lipoproteins with dimyristoyllecithin multilamellar liposomes.

Authors:  A R Tall; V Hogan; L Askinazi; D M Small
Journal:  Biochemistry       Date:  1978-01-24       Impact factor: 3.162

Review 4.  High density lipoprotein structure-function and role in reverse cholesterol transport.

Authors:  Sissel Lund-Katz; Michael C Phillips
Journal:  Subcell Biochem       Date:  2010

5.  ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions.

Authors:  Ashley M Vaughan; John F Oram
Journal:  J Lipid Res       Date:  2003-04-16       Impact factor: 5.922

6.  The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.

Authors:  Fatiha Tabet; Alan T Remaley; Aude I Segaliny; Jonathan Millet; Ling Yan; Shirley Nakhla; Philip J Barter; Kerry-Anne Rye; Gilles Lambert
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-03       Impact factor: 8.311

Review 7.  HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.

Authors:  Alan T Remaley; Marcelo Amar; Dmitri Sviridov
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-10

8.  An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide.

Authors:  Geoffrey D Wool; Tomas Vaisar; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2009-05-11       Impact factor: 5.922

9.  Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway.

Authors:  Alan T Remaley; Fairwell Thomas; John A Stonik; Steve J Demosky; Samantha E Bark; Edward B Neufeld; Alexander V Bocharov; Tatyana G Vishnyakova; Amy P Patterson; Thomas L Eggerman; Silvia Santamarina-Fojo; H Bryan Brewer
Journal:  J Lipid Res       Date:  2003-01-16       Impact factor: 5.922

View more
  7 in total

1.  A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE-/- mice.

Authors:  Sanhu Gou; Li Wang; Chao Zhong; Xinyue Chen; Xu Ouyang; Beibei Li; Guangjun Bao; Hui Liu; Yun Zhang; Jingman Ni
Journal:  Br J Pharmacol       Date:  2020-09-09       Impact factor: 8.739

2.  Helical domains that mediate lipid solubilization and ABCA1-specific cholesterol efflux in apolipoproteins C-I and A-II.

Authors:  Loren E Smith; Jere P Segrest; W Sean Davidson
Journal:  J Lipid Res       Date:  2013-04-25       Impact factor: 5.922

3.  Serum apolipoprotein A-I depletion is causative to silica nanoparticles-induced cardiovascular damage.

Authors:  Xuting Liu; Wei Wei; Zixuan Liu; Erqun Song; Jianlin Lou; Lingfang Feng; Rongchong Huang; Chunying Chen; Pu Chun Ke; Yang Song
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-02       Impact factor: 11.205

4.  High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.

Authors:  Una L Kelly; Daniel Grigsby; Martha A Cady; Michael Landowski; Nikolai P Skiba; Jian Liu; Alan T Remaley; Mikael Klingeborn; Catherine Bowes Rickman
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

5.  Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.

Authors:  Anouar Hafiane; John K Bielicki; Jan O Johansson; Jacques Genest
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

6.  Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux.

Authors:  Rafique M Islam; Mohsen Pourmousa; Denis Sviridov; Scott M Gordon; Edward B Neufeld; Lita A Freeman; B Scott Perrin; Richard W Pastor; Alan T Remaley
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

7.  ABCA1 (ATP-Binding Cassette Transporter A1) Mediates ApoA-I (Apolipoprotein A-I) and ApoA-I Mimetic Peptide Mobilization of Extracellular Cholesterol Microdomains Deposited by Macrophages.

Authors:  Xueting Jin; Denis Sviridov; Ying Liu; Boris Vaisman; Lia Addadi; Alan T Remaley; Howard S Kruth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-06       Impact factor: 8.311

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.